How should the ERS respond?

A. Bush (London, United Kingdom)

Source: Annual Congress 2006 - Medicines for children: the impact of proposed new EU legislation
Session: Medicines for children: the impact of proposed new EU legislation
Session type: Hot topics
Number: 4795

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bush (London, United Kingdom). How should the ERS respond?. Annual Congress 2006 - Medicines for children: the impact of proposed new EU legislation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007


Effect of reflexology, homeopathy, and traditional medical treatment in asthma: A randomised, controlled, parallel-group trial
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010


A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



The power nap - a work place benefit? A randomised controlled trial
Source: Eur Respir J 2005; 26: Suppl. 49, 570s
Year: 2005

Reframing asthma and inhaled corticosteroids (ICS) to modify treatment beliefs: an online randomised controlled trial
Source: International Congress 2018 – Educational tools to improve your practice
Year: 2018



Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial.
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020
Year: 2020



“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial)
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


Randomized controlled trial of a multi-facetted intervention initiated in the emergency department (ED) to improve asthma control
Source: Annual Congress 2009 - Impact of asthma on children's lives and the effects of education
Year: 2009

Does the provision of a written action plan in the emergency department (ED) improve adherence to physicians‘ recommendations and asthma control in children with acute asthma? A randomized controlled trial
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Can internet-based monitoring of asthma maintain asthma control over a 12-month period?
Source: Annual Congress 2006 - New developments in the treatment and management of asthma
Year: 2006


The impact of a professional development plan (PDP) on the management of acute asthma in UK primary care: a randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 355s
Year: 2003

Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase)
Source: Eur Respir J, 58 (2) 2002139; 10.1183/13993003.02139-2020
Year: 2021



Run-in bias in randomised trials: the case of COPD medications
Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017
Year: 2017



Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016

An education program for asthma and COPD patients conducted by a general practice assistant; a randomised controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 396s
Year: 2002